0001628280-23-003706.txt : 20230215 0001628280-23-003706.hdr.sgml : 20230215 20230215161652 ACCESSION NUMBER: 0001628280-23-003706 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230213 FILED AS OF DATE: 20230215 DATE AS OF CHANGE: 20230215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NEIL GARRY ARTHUR CENTRAL INDEX KEY: 0001586785 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 23635574 MAIL ADDRESS: STREET 1: 555 CALIFORNIA STREET STREET 2: SUITE 365 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 4 1 wf-form4_167649579442477.xml FORM 4 X0306 4 2023-02-13 0 0001534120 Avalo Therapeutics, Inc. AVTX 0001586785 NEIL GARRY ARTHUR C/O AVALO THERAPEUTICS 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 1 1 0 0 CEO and Chairman of the Board Stock Option (Right to Buy) 2.98 2023-02-13 4 A 0 100000 0 A 2033-02-13 Common Stock 100000.0 100000 D One-fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each applicable vesting date. /s/ Jennifer Zoltoski, by Power of Attorney 2023-02-15